Mesoblast CEO to Deliver Featured Presentation at ISCT North America Virtual Town Hall
NEW YORK, March 12, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory...
Day: March 12, 2025
Theratechnologies CROI Presentation Highlights Limitations of Using BMI to Assess Cardiovascular (CV) Risk in People with HIV
Study Demonstrates Excess Visceral Abdominal Fat Drives CV RiskMONTREAL, March 12, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the...
Sagimet Biosciences Reports Full Year 2024 Financial Results and Provides Corporate Updates
Denifanstat Phase 3 MASH program initiated in Q4 2024; patient screening expected to start in 1H 2025 Denifanstat received Breakthrough...
Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results
HOLLISTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for...
Prime Biome Reviews And Complaints: A Detailed Study Released That’s Needs to Be Adopted for Which Type of Peoples?
ST. PETERSBURG, Fla., March 12, 2025 (GLOBE NEWSWIRE) -- This is a comprehensive examination of the groundbreaking research behind Prime...
Clearside Biomedical to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update on Thursday, March 27, 2025
ALPHARETTA, Ga., March 12, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing...
Amarin Announces Plan to Initiate a Ratio Change Under Its American Depository Receipt (ADR) Program
1-For-20 Ratio Change Initiated to Increase Per Share Market Price of Amarin’s ADSs in Effort to Maintain Nasdaq ListingDUBLIN and...
Bavarian Nordic A/S – Notice Convening Annual General Meeting
COPENHAGEN, Denmark, March 12, 2025 – Pursuant to Articles 10-14 of the Articles of Association, the shareholders of Bavarian Nordic...
ROSE LifeScience Expands Pure Laine and Tam Tams Lineups with New Pre-Rolls, Vapes, and Fan-Favourite Cultivars for Winter 2025
Pure Laine Originals Greatest Hits Vape Cartridges Pure Laine Selects Special Haze & Original Kush Slims Tam Tams Summer Sundaze...
Upstream Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
– Completed enrollment of Phase 2 clinical trial of verekitug in patients with chronic rhinosinusitis with nasal polyps; top-line data...
Amarin Reports Fourth Quarter Financial Results & Business Update and Announces Important Corporate Action
-- Company Reports Fourth Quarter 2024 Total Revenues of $62.3 Million, Operating Expenses of $43.0 Million and Year End 2024...
InspireMD Reports Fourth Quarter and Full Year 2024 Financial Results
Management to host investor conference call today, March 12th, at 8:30am ETMIAMI, March 12, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc....
Tilray Grows Its Non-Alcoholic Craft Beer Line, Runner’s High Brewing, Across the East Coast and Mid-West Regions
Runner’s High Connects with Social Running Communities and Caters to Lifestyle Preferences with its Low-Calorie Brews NEW YORK, March 12,...
PatchMD Introduces New GLP-1 Support Patches for Individuals on Weight Loss Medications
HENDERSON, NV, March 12, 2025 (GLOBE NEWSWIRE) -- PatchMD, a leading innovator in transdermal nutrient delivery, is excited to announce...
CENTOGENE Closes Strategic Transaction with Private Equity Group Charme Capital Partners
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, March 12, 2025 (GLOBE NEWSWIRE) -- Centogene N.V. (OTC: CNTGF) (“CENTOGENE” or the...
Shuttle Pharma Announces Appointment of Christopher Cooper as Interim Co-CEO to Enhance Business Activities
Dr. Anatoly Dritschilo remains Chairman of the Board and Co-CEO overseeing scientific and clinical trial activitiesGAITHERSBURG, Md., March 12, 2025...
Inaugural Global Longevity Summit Architects New Horizons In Human Health Potential
Informa Connect Medical Division announces landmark Geneva-based conference, convening the world's foremost industry leaders to forge strategic partnerships, accelerate breakthroughs,...
HOOPP achieves a 9.7% return in 2024 amid global economic and geopolitical instability
HOOPP Chief Investment Officer Michael Wissell HOOPP President and Chief Executive Officer Jeff Wendling TORONTO, March 12, 2025 (GLOBE NEWSWIRE)...
Philips highest ranked medical technology company among Clarivate Top 100 Global Innovators
Dual AI engines in SmartSpeed Precise CT 5300 with AI-enabled workflow Azurion neuro biplane AI-enabled cardiovascular ultrasound platform March 12,...
Angelini Ventures leads €10 million Series A financing in Vantis, a Digital Care Innovation company
Strategic investment in digital health solutions addressing critical challenges in primary care and chronic disease management Rome, Italy, 12 March...